✦ LIBER ✦

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Scribed by Carlo Garufi; Barbara Vanni; Anna Maria Aschelter; Albina Rita Zappalà; Emilio Bria; Cecila Nisticò; Isabella Sperduti; Francesco Cognetti; Edmondo Terzoli

Book ID: 116428549
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 166 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

High-dose chronomodulated infusion of 5-

High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients

✍ Edmondo Terzoli; Carlo Garufi; Albina Rita Zappalà; Barbara Vanni; Patrizia Pugl 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized

Irinotecan and chronomodulated infusion

Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma : A Phase I study

✍ Carlo Garufi; Luigi Dogliotti; Rita M. D'Attino; Marco Tampellini; Anna M. Asche 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

A phase I trial of 5-day chronomodulated

A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer

✍ C. Garufi; F. Lévi; A.M. Aschelter; R. Pace; S. Giunta; C. Nisticó; D.A.P. Gallà 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 766 KB

Phase I – II study to assess the feasibi

Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study

✍ Focan, C.; Kreutz, F.; Graas, M.-P.; Longrée, L.; Focan-Henrard, D.; Demolin, G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 429 KB